[
    {
        "question_id": "999_B_1351",
        "new_question_id": "59415",
        "question_type": "0",
        "category": "12",
        "concept_id_link": "1499",
        "notes_id_link": "1_836",
        "theme": "First-line pharmacological management in newly diagnosed COPD",
        "instruction": "",
        "options": [
            "",
            "Short-acting beta<sub>2</sub>-agonist inhaler",
            "Long-acting muscarinic antagonist inhaler",
            "Inhaled corticosteroid and LABA combination inhaler",
            "Theophylline tablets",
            "Azithromycin prophylaxis",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 70-year-old woman attends her GP with gradually worsening exertional breathlessness over the past year. She has a 35-pack-year smoking history, no previous diagnosis of asthma or allergies, and currently takes no regular medication. Examination reveals scattered expiratory wheeze but is otherwise unremarkable. Spirometry confirms airflow obstruction consistent with COPD. Her bloods show:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Eosinophils</td><td>0.1 \u00d710<sup>9</sup>/L</td><td>(0.0\u20130.4)</td></tr></tbody></table></div>She wishes to discuss treatment options for symptom relief.<br /><br />What is the most appropriate initial pharmacological therapy to offer?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>Short-acting beta<sub>2</sub>-agonist inhaler</b>: This is the correct answer because NICE guidelines recommend either a short-acting beta<sub>2</sub>-agonist (SABA) or short-acting muscarinic antagonist (SAMA) as first-line pharmacological management for symptomatic COPD patients without features suggesting steroid responsiveness or asthma. The patient\u2019s lack of asthmatic features (no prior diagnosis, atopy, or eosinophilia; low eosinophil count here) supports this approach. SABAs provide rapid symptom relief and are well tolerated as initial therapy while further assessment and non-pharmacological interventions are also addressed.<br /><br /><b>Long-acting muscarinic antagonist inhaler</b>: While LAMAs are effective in COPD management, they are not recommended as first-line monotherapy for initial symptom control in newly diagnosed patients who have not trialled short-acting bronchodilators per NICE guidance. LAMAs may be added if symptoms persist despite SABA/SAMA use.<br /><br /><b>Inhaled corticosteroid and LABA combination inhaler</b>: This option is indicated if there are asthmatic features or evidence of steroid responsiveness (such as elevated eosinophils, significant FEV1 variability, atopy), none of which are present in this scenario. Starting with ICS/LABA would be premature and outside guideline recommendations for this patient profile.<br /><br /><b>Theophylline tablets</b>: Oral theophylline should only be considered after trials of both short- and long-acting bronchodilators or when inhaled therapies cannot be used due to contraindications or intolerance. It carries side effects and requires monitoring; it is not suitable as an initial step.<br /><br /><b>Azithromycin prophylaxis</b>: Prophylactic macrolides like azithromycin are reserved for patients with frequent exacerbations despite optimal standard therapy\u2014including maximised inhaled treatment\u2014and who do not smoke; this patient does not meet these criteria.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 70-year-old woman attends her GP with gradually worsening exertional breathlessness over the past year. She has a 35-pack-year smoking history, no previous diagnosis of asthma or allergies, and currently takes no regular medication. Examination reveals scattered expiratory wheeze but is otherwise unremarkable. Spirometry confirms airflow obstruction consistent with COPD. Her bloods show:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Eosinophils</td><td>0.1 \u00d710<sup>9</sup>/L</td><td>(0.0\u20130.4)</td></tr></tbody></table></div>She wishes to discuss treatment options for symptom relief.<br /><br />What is the most appropriate initial pharmacological therapy to offer?",
        "correct_answer": "1",
        "question_notes": "<b>Short-acting beta<sub>2</sub>-agonist inhaler</b>: This is the correct answer because NICE guidelines recommend either a short-acting beta<sub>2</sub>-agonist (SABA) or short-acting muscarinic antagonist (SAMA) as first-line pharmacological management for symptomatic COPD patients without features suggesting steroid responsiveness or asthma. The patient\u2019s lack of asthmatic features (no prior diagnosis, atopy, or eosinophilia; low eosinophil count here) supports this approach. SABAs provide rapid symptom relief and are well tolerated as initial therapy while further assessment and non-pharmacological interventions are also addressed.<br /><br /><b>Long-acting muscarinic antagonist inhaler</b>: While LAMAs are effective in COPD management, they are not recommended as first-line monotherapy for initial symptom control in newly diagnosed patients who have not trialled short-acting bronchodilators per NICE guidance. LAMAs may be added if symptoms persist despite SABA/SAMA use.<br /><br /><b>Inhaled corticosteroid and LABA combination inhaler</b>: This option is indicated if there are asthmatic features or evidence of steroid responsiveness (such as elevated eosinophils, significant FEV1 variability, atopy), none of which are present in this scenario. Starting with ICS/LABA would be premature and outside guideline recommendations for this patient profile.<br /><br /><b>Theophylline tablets</b>: Oral theophylline should only be considered after trials of both short- and long-acting bronchodilators or when inhaled therapies cannot be used due to contraindications or intolerance. It carries side effects and requires monitoring; it is not suitable as an initial step.<br /><br /><b>Azithromycin prophylaxis</b>: Prophylactic macrolides like azithromycin are reserved for patients with frequent exacerbations despite optimal standard therapy\u2014including maximised inhaled treatment\u2014and who do not smoke; this patient does not meet these criteria.",
        "answer_order": "1",
        "answer": "1",
        "title": "COPD: stable management",
        "body": "NICE updated its guidelines on the management of chronic obstructive pulmonary disease (COPD) in 2018.<br /><br />General management<br /><ul><li><span class=\"concept\" data-cid=\"4006\">>smoking cessation</span> advice: including offering nicotine replacement therapy, varenicline or bupropion</li><li>annual influenza vaccination</li><li>one-off pneumococcal vaccination</li><li><span class=\"concept\" data-cid=\"3990\">pulmonary rehabilitation</span> to all people who view themselves as functionally disabled by COPD (usually Medical Research Council [MRC] grade 3 and above)</li></ul><br />Bronchodilator therapy<br /><ul><li><span class=\"concept\" data-cid=\"1499\">a short-acting beta2-agonist (SABA) or short-acting muscarinic antagonist (SAMA) is first-line treatment</span></li><li>for patients who remain breathless or have exacerbations despite using short-acting bronchodilators the next step is determined by whether the patient has <i>'asthmatic features/features suggesting steroid responsiveness'</i></li></ul><br />There are a <span class=\"concept\" data-cid=\"9525\">number of criteria NICE suggest to determine whether a patient has asthmatic/steroid responsive features:</span><br /><ul><li>any previous, secure diagnosis of asthma or of atopy</li><li>a higher blood eosinophil count - note that NICE recommend a full blood count for all patients as part of the work-up</li><li>substantial variation in FEV1 over time (at least 400 ml)</li><li>substantial diurnal variation in peak expiratory flow (at least 20%)</li></ul><br />Interestingly NICE do not recommend formal reversibility testing as one of the criteria. In the guidelines they state that <i>'routine spirometric reversibility testing is not necessary as part of the diagnostic process or to plan initial therapy with bronchodilators or corticosteroids. It may be unhelpful or misleading...'</i>. They then go on to discuss why they have reached this conclusion. Please see the guidelines for more details.<br /><br />No asthmatic features/features suggesting steroid responsiveness<br /><ul><li><span class=\"concept\" data-cid=\"889\">add a long-acting beta2-agonist (LABA) + long-acting muscarinic antagonist (LAMA)</span><ul><li><span class=\"concept\" data-cid=\"7723\">if already taking a SAMA, discontinue and switch to a SABA</span></li></ul></li></ul><br />Asthmatic features/features suggesting steroid responsiveness<br /><ul><li><span class=\"concept\" data-cid=\"890\">LABA + inhaled corticosteroid (ICS)</span></li><li>if patients remain breathless or have exacerbations offer <span class=\"concept\" data-cid=\"7505\">triple therapy i.e. LAMA + LABA + ICS</span><ul><li><span class=\"concept\" data-cid=\"7723\">if already taking a SAMA, discontinue and switch to a SABA</span></li></ul></li><li>NICE recommend the use of combined inhalers where possible</li><li>NICE specifically mention the <span class=\"concept\" data-cid=\"12493\">risk of pneumonia</span> in patients with COPD using inhaled corticosteroids</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd542b.png\" data-fancybox=\"gallery\" data-caption=\"NICE 2018 COPD guidelines - simplified flowchart\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd542.png\" alt=\"\" /></a></div></div></div><br />Oral theophylline<br /><ul><li>NICE only recommends theophylline after trials of short and long-acting bronchodilators or to people who cannot used inhaled therapy</li><li>the dose should be reduced if macrolide or fluoroquinolone antibiotics are co-prescribed</li></ul><br />Oral prophylactic antibiotic therapy<br /><ul><li><span class=\"concept\" data-cid=\"9761\">azithromycin prophylaxis is recommended in select patients</span></li><li>patients <span class=\"concept\" data-cid=\"10638\">should not smoke</span>, have optimised standard treatments and continue to have exacerbations</li><li>other prerequisites include a CT thorax (to exclude bronchiectasis) and sputum culture (to exclude atypical infections and tuberculosis)</li><li>LFTs and an <span class=\"concept\" data-cid=\"9526\">ECG to exclude QT prolongation should also be done as azithromycin can prolong the QT interval</span></li></ul><br /><span class=\"concept\" data-cid=\"12253\">Standby medication: NICE recommend offering a short course of oral corticosteroids and oral antibiotics</span> to keep at home if:  <a href='https://www.nice.org.uk/guidance/ng115/chapter/Recommendations#managing-stable-copd:~:text=Offer%20people%20a%20short%20course%20of%20oral%20corticosteroids%20and%20a%20short%20course%20of%20oral%20antibiotics%20to%20keep%20at%20home%20as%20part%20of%20their%20exacerbation%20action%20plan%20if%3A' title='NICE - 2018 COPD guidelines' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE</a> <br /><ul><li>have had an exacerbation within the last year</li><li>understand how to take the medication, and are aware of associated risks and benefits</li><li>know to when to seek help and when to ask for replacements once medication has been used</li></ul><br />Mucolytics<br /><ul><li>should be 'considered' in patients with a chronic productive cough and continued if symptoms improve</li></ul><br /><span class=\"concept\" data-cid=\"12077\">Phosphodiesterase-4 (PDE-4) inhibitors</span>  <a href='https://www.nice.org.uk/guidance/ta461/chapter/1-Recommendations#:~:text=1-,Recommendations,-1.1' title='NICE - Roflumilast NICE recommendations' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE</a> <br /><ul><li>oral PDE-4 inhibitors such as roflumilast reduce the risk of COPD exacerbations in patients with severe COPD and a history of frequent COPD exacerbations</li><li>NICE recommend if:<ul><li>the disease is severe, defined as a forced expiratory volume in 1 second (FEV1) after a bronchodilator of less than 50% of predicted normal, and</li><li>the person has had 2 or more exacerbations in the previous 12 months despite triple inhaled therapy with a long-acting muscarinic antagonist, a long-acting beta-2 agonist and an inhaled corticosteroid</li></ul></li></ul><br />Cor pulmonale<br /><ul><li>features include peripheral oedema, raised jugular venous pressure, systolic parasternal heave, loud P2</li><li>use a loop diuretic for oedema, consider long-term oxygen therapy</li><li>ACE-inhibitors, calcium channel blockers and alpha blockers are not recommended by NICE</li></ul><br />Factors which may improve survival in patients with stable COPD<br /><ul><li>smoking cessation - the single most important intervention in patients who are still smoking </li><li>long term oxygen therapy in patients who fit criteria </li><li>lung volume reduction surgery in selected patients</li></ul>",
        "notes_hash": "1b3e15be8109654eb018de2330833108",
        "knowledge_graph_node_id_link": 0,
        "concept": "A SABA or SAMA is the first-line pharmacological treatment of COPD",
        "concept_percentile": "94",
        "concept_colour": "rgb(30,255,0)",
        "number_attempts": "5363",
        "up_votes": "3",
        "down_votes": "6",
        "column_array": [
            0,
            "3787",
            "622",
            "912",
            "17",
            "25",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Global Initiative for Chronic Obstructive Lung Disease</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_40\" data-linkid=\"40\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_40\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">25</span><button type=\"button\" style=\"\" id=\"link_dislike_40\" data-linkid=\"40\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_40\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">39</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://goldcopd.org/\">GOLD criteria 2017</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1362\" data-linkid=\"1362\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1362\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">19</span><button type=\"button\" style=\"\" id=\"link_dislike_1362\" data-linkid=\"1362\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1362\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">21</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/TA461/chapter/1-Recommendations\">Roflumilast NICE recommendations</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1202\" data-linkid=\"1202\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1202\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">35</span><button type=\"button\" style=\"\" id=\"link_dislike_1202\" data-linkid=\"1202\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1202\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">33</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng115/chapter/Recommendations\">2018 COPD guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1429\" data-linkid=\"1429\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1429\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">50</span><button type=\"button\" style=\"\" id=\"link_dislike_1429\" data-linkid=\"1429\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1429\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">16</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng115/resources/visual-summary-treatment-algorithm-pdf-6604261741\">2018 COPD management diagram</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/f/f3/Chronic_bronchitis.webm\" data-description=\"Chronic bronchitis\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"984\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/f/f3/Chronic_bronchitis.webm\" data-description=\"Chronic bronchitis\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"984\">Chronic bronchitis</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1710\" data-mediaid=\"1710\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1710\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_1710\" data-mediaid=\"1710\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1710\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/GGkajjvMEAQ\" data-description=\"Cor pulmonale\" data-upvotes=\"8\" data-downvotes=\"3\" data-media=\"1291\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/GGkajjvMEAQ/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/GGkajjvMEAQ\" data-description=\"Cor pulmonale\" data-upvotes=\"8\" data-downvotes=\"3\" data-media=\"1291\">Cor pulmonale</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2286\" data-mediaid=\"2286\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2286\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"media_dislike_2286\" data-mediaid=\"2286\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2286\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/UQGRcg35Dmk\" data-description=\"Cor pulmonale\" data-upvotes=\"7\" data-downvotes=\"3\" data-media=\"897\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/UQGRcg35Dmk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/UQGRcg35Dmk\" data-description=\"Cor pulmonale\" data-upvotes=\"7\" data-downvotes=\"3\" data-media=\"897\">Cor pulmonale</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1562\" data-mediaid=\"1562\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1562\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"media_dislike_1562\" data-mediaid=\"1562\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1562\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/XBg6hxGgyS4\" data-description=\"Understanding COPD\" data-upvotes=\"2\" data-downvotes=\"4\" data-media=\"1468\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/XBg6hxGgyS4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/XBg6hxGgyS4\" data-description=\"Understanding COPD\" data-upvotes=\"2\" data-downvotes=\"4\" data-media=\"1468\">Understanding COPD</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2588\" data-mediaid=\"2588\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2588\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2588\" data-mediaid=\"2588\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2588\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 1,
        "concepts_for_notes": {
            "889": {
                "concept_text": "COPD - still breathless despite using SABA/SAMA and <b>no</b> asthma/steroid responsive features --> add a LABA + LAMA",
                "concept_percentile": "70"
            },
            "890": {
                "concept_text": "COPD - still breathless despite using SABA/SAMA and <b>asthma/steroid responsive features</b> --> add a LABA + ICS",
                "concept_percentile": "50"
            },
            "1499": {
                "concept_text": "A SABA or SAMA is the first-line pharmacological treatment of COPD",
                "concept_percentile": "94"
            },
            "7505": {
                "concept_text": "COPD - still breathless despite using SABA/SAMA and a LABA + ICS --> add a LAMA",
                "concept_percentile": "60"
            },
            "9525": {
                "concept_text": "Asthmatic features/features suggesting steroid responsiveness in COPD: \r\n   - previous diagnosis of asthma or atopy\r\n   - a higher blood eosinophil count\r\n   - substantial variation in FEV1 over time (at least 400 ml)\r\n   - substantial diurnal variation in peak expiratory flow (at least 20%)",
                "concept_percentile": "79"
            },
            "9761": {
                "concept_text": "Azithromycin prophylaxis is recommended in COPD patients who meet certain criteria and who continue to have exacerbations",
                "concept_percentile": "87"
            },
            "12253": {
                "concept_text": "COPD standby medication: NICE recommend offering a short course of oral corticosteroids and oral antibiotics to keep at home",
                "concept_percentile": "98"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2066",
        "new_question_id": "3399",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_1571",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Citalopram",
            "Evening primrose oil",
            "Tibolone",
            "Goserelin",
            "Propranolol",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 50-year-old woman presents asking for advice regarding the management of her climacteric symptoms. Her periods have recently stopped and she is troubled by night sweats and hot flushes. She does not want hormone replacement therapy as her sister died of breast cancer. Which one of the following is the most appropriate treatment to recommend?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "The most appropriate treatment to recommend for this patient is <b>Citalopram</b>. Citalopram is a selective serotonin reuptake inhibitor (SSRI) that has been shown to be effective in reducing the frequency and severity of hot flushes and night sweats in menopausal women who do not wish to take hormone replacement therapy (HRT). The use of SSRIs for this indication is supported by UK guidelines.<br /><br /><b>Evening primrose oil</b> has been traditionally used as a natural remedy for various ailments, including menopausal symptoms. However, there is limited evidence supporting its efficacy in treating hot flushes and night sweats, making it a less suitable option compared to Citalopram.<br /><br /><b>Tibolone</b> is a synthetic steroid hormone with estrogenic, progestogenic, and weak androgenic properties. It can be used as an alternative to HRT for the treatment of menopausal symptoms. However, since the patient specifically mentioned that she does not want HRT due to her sister's history of breast cancer, Tibolone would not be an appropriate choice.<br /><br /><b>Goserelin</b> is a gonadotropin-releasing hormone (GnRH) agonist that acts by suppressing ovarian function. It may actually exacerbate menopausal symptoms such as hot flushes and night sweats rather than alleviating them. Additionally, Goserelin is primarily used in the management of endometriosis or advanced prostate cancer and would not be suitable for managing climacteric symptoms in this case.<br /><br />Finally, <b>Propranolol</b> is a non-selective beta-blocker commonly used for managing hypertension, angina pectoris, or essential tremor. While it may help reduce some anxiety-related symptoms associated with menopause, it has no specific efficacy in treating hot flushes or night sweats and would not be the best choice for this patient.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 50-year-old woman presents asking for advice regarding the management of her climacteric symptoms. Her periods have recently stopped and she is troubled by night sweats and hot flushes. She does not want hormone replacement therapy as her sister died of breast cancer. Which one of the following is the most appropriate treatment to recommend?",
        "correct_answer": "1",
        "question_notes": "The most appropriate treatment to recommend for this patient is <b>Citalopram</b>. Citalopram is a selective serotonin reuptake inhibitor (SSRI) that has been shown to be effective in reducing the frequency and severity of hot flushes and night sweats in menopausal women who do not wish to take hormone replacement therapy (HRT). The use of SSRIs for this indication is supported by UK guidelines.<br /><br /><b>Evening primrose oil</b> has been traditionally used as a natural remedy for various ailments, including menopausal symptoms. However, there is limited evidence supporting its efficacy in treating hot flushes and night sweats, making it a less suitable option compared to Citalopram.<br /><br /><b>Tibolone</b> is a synthetic steroid hormone with estrogenic, progestogenic, and weak androgenic properties. It can be used as an alternative to HRT for the treatment of menopausal symptoms. However, since the patient specifically mentioned that she does not want HRT due to her sister's history of breast cancer, Tibolone would not be an appropriate choice.<br /><br /><b>Goserelin</b> is a gonadotropin-releasing hormone (GnRH) agonist that acts by suppressing ovarian function. It may actually exacerbate menopausal symptoms such as hot flushes and night sweats rather than alleviating them. Additionally, Goserelin is primarily used in the management of endometriosis or advanced prostate cancer and would not be suitable for managing climacteric symptoms in this case.<br /><br />Finally, <b>Propranolol</b> is a non-selective beta-blocker commonly used for managing hypertension, angina pectoris, or essential tremor. While it may help reduce some anxiety-related symptoms associated with menopause, it has no specific efficacy in treating hot flushes or night sweats and would not be the best choice for this patient.",
        "answer_order": "1",
        "answer": "1",
        "title": "Menopause: management",
        "body": "Menopause is defined as the permanent cessation of menstruation. It is caused by the loss of follicular activity. Menopause is a clinical diagnosis usually made in primary care when a woman has not had a period for 12 months. <br /><br />Menopausal symptoms are very common and affect roughly 75% of postmenopausal women. Symptoms typically last for 7 years but may resolve quicker and in some cases take much longer. The duration and severity are also variable and may develop before the start of the menopause and in some cases may start years after the onset of menopause.  <br /><br />The CKS has very thorough and clear guidance on the management of menopause and is summarised below. <br /><br />The management of menopause can be split into three categories:<br /><ul><li>Lifestyle modifications</li><li>Hormone replacement therapy (HRT)</li><li>Non-hormone replacement therapy </li></ul><br /><br /><h5 class='notes-heading'>Management with lifestyle modifications</h5><br />Hot flushes<br /><ul><li>regular exercise, weight loss and reduce stress</li></ul><br />Sleep disturbance<br /><ul><li>avoiding late evening exercise and maintaining good sleep hygiene </li></ul><br />Mood<br /><ul><li>sleep, regular exercise and relaxation</li></ul><br />Cognitive symptoms<br /><ul><li>regular exercise and good sleep hygiene </li></ul><br /><br /><h5 class='notes-heading'>Management with HRT</h5><br />Contraindications: <br /><ul><li>Current or past breast cancer</li><li>Any oestrogen-sensitive cancer </li><li>Undiagnosed vaginal bleeding</li><li>Untreated endometrial hyperplasia </li></ul><br />Roughly 10% of women will have some form of HRT to treat their menopausal symptoms. There is a current drive by NICE to increase this number as they have found that women were previously being undertreated due to worries about increased cancer risk. If the woman has a uterus then it is important not to give unopposed oestrogens as this will increase her risk of endometrial cancer. Therefore oral or transdermal combined HRT is given.<br /><br />If the woman does not have a uterus then oestrogen alone can be given either orally or in a transdermal patch.<br /> <br />Women should be advised that the symptoms of menopause typically last for 2-5 years and that treatment with HRT brings certain risks:<br /><ul><li>Venous thromboembolism: a slight increase in risk with all forms of oral HRT. No increased risk with transdermal HRT. </li><li>Stroke: slightly increased risk with oral oestrogen HRT.</li><li>Coronary heart disease: combined HRT may be associated with a slight increase in risk.</li><li>Breast cancer: there is an increased risk with all combined HRT although the risk of dying from breast cancer is not raised. </li><li>Ovarian cancer: increased risk with all HRT.</li></ul><br /><h5 class='notes-heading'>Management with non-HRT</h5><br />Vasomotor symptoms<br /><ul><li><span class=\"concept\" data-cid=\"3065\">fluoxetine, citalopram or venlafaxine</span> </li></ul><br />Vaginal dryness<br /><ul><li>vaginal lubricant or moisturiser </li></ul><br />Psychological symptoms<br /><ul><li>self-help groups, cognitive behaviour therapy or antidepressants</li></ul><br />Urogenital symptoms<br /><ul><li>if suffering from urogenital atrophy vaginal oestrogen can be prescribed. This is appropriate if they are taking HRT or not</li><li>vaginal dryness can be treated with moisturisers and lubricants. These can be offered alongside vaginal oestrogens if required. </li></ul><br /><br /><h5 class='notes-heading'>Stopping treatment</h5><br />For vasomotor symptoms, 2-5 years of HRT may be required with regular attempts made to discontinue treatment. Vaginal oestrogen may be required long term. When stopping HRT it is important to tell women that gradually reducing HRT is effective at limiting recurrence only in the short term. In the long term, there is no difference in symptom control. <br /><br />Although menopausal symptoms can be managed mainly in primary care, there are some instances when a woman should be referred to secondary care. She should be referred to secondary care if treatment has been ineffective, if there are ongoing side effects or if there is unexplained bleeding.",
        "notes_hash": "58e05deffbd4e95e6bd21ab6aabfdf67",
        "knowledge_graph_node_id_link": 1160,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6108",
        "up_votes": "20",
        "down_votes": "14",
        "column_array": [
            0,
            "3442",
            "884",
            "466",
            "457",
            "859",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hjBxRLhyd2I\" data-description=\"Menopause\" data-upvotes=\"5\" data-downvotes=\"4\" data-media=\"470\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/hjBxRLhyd2I/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hjBxRLhyd2I\" data-description=\"Menopause\" data-upvotes=\"5\" data-downvotes=\"4\" data-media=\"470\">Menopause</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_825\" data-mediaid=\"825\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_825\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_825\" data-mediaid=\"825\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_825\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rxZBn88iUlM\" data-description=\"Premature ovarian failure\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"384\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/rxZBn88iUlM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rxZBn88iUlM\" data-description=\"Premature ovarian failure\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"384\">Premature ovarian failure</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_658\" data-mediaid=\"658\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_658\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_658\" data-mediaid=\"658\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_658\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "3065": {
                "concept_text": "Selective serotonin reuptake inhibitors and venlafaxine are non-hormonal methods that may help vasomotor symptoms of menopause",
                "concept_percentile": "99"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "4693_B_23",
        "new_question_id": "16186",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "4358",
        "notes_id_link": "1_2472",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Corneal ulcer",
            "Dry eye syndrome",
            "Allergic conjunctivitis",
            "Uveitis",
            "Scleritis",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 54-year-old man presents to his general practitioner complaining of bilateral gritty, sore eyes; it has been present for a number of weeks. He denies trauma and has had no discharge. He has not noticed any blurred vision. His past medical history is significant only for back pain, for which he is taking paracetamol and amitriptyline. On examination, his visual acuity is 6/6 corrected bilaterally, he has no obvious corneal or pupillary abnormality, his eyes are not red and eye movements are normal.<br /><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "Bilateral sore eyes with a gritty or burning sensation is often caused by dry eyes, which can be managed with topical lubrication such as hypromellose. Examination may be normal, but fluorescein staining can reveal superficial punctate staining and Schirmer's test may show reduced tear production.<br /><br />Allergic conjunctivitis is a key differential; the clue here is the length of time of symptoms and lack of ocular signs to suggest conjunctival involvement.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 54-year-old man presents to his general practitioner complaining of bilateral gritty, sore eyes; it has been present for a number of weeks. He denies trauma and has had no discharge. He has not noticed any blurred vision. His past medical history is significant only for back pain, for which he is taking paracetamol and amitriptyline. On examination, his visual acuity is 6/6 corrected bilaterally, he has no obvious corneal or pupillary abnormality, his eyes are not red and eye movements are normal.<br /><br />What is the most likely diagnosis?",
        "correct_answer": "2",
        "question_notes": "Bilateral sore eyes with a gritty or burning sensation is often caused by dry eyes, which can be managed with topical lubrication such as hypromellose. Examination may be normal, but fluorescein staining can reveal superficial punctate staining and Schirmer's test may show reduced tear production.<br /><br />Allergic conjunctivitis is a key differential; the clue here is the length of time of symptoms and lack of ocular signs to suggest conjunctival involvement.",
        "answer_order": "2",
        "answer": "2",
        "title": "Dry eyes",
        "body": "People with dry eye syndrome typically present with feelings of dryness, grittiness, or soreness in both eyes, which worsen through the day, and watering of the eyes, particularly when exposed to wind. Symptoms that are worse on wakening, eyelids sticking together on waking, and redness of the eyelids suggest dry eye syndrome caused by Meibomian gland dysfunction. <br /><br />There may be no abnormalities on examination. Less commonly people present with a complication of dry eye syndrome, for example, conjunctivitis or ulceration of the cornea, suggested by severe pain, photophobia, marked redness, and loss of visual acuity.<br /><br />Eyelid hygiene is the most appropriate management step here. Eyelid hygiene helps to control blepharitis. Most people with dry eye syndrome have blepharitis. ",
        "notes_hash": "aa05b3727b493235c92c3ab2e7a071fb",
        "knowledge_graph_node_id_link": 10281,
        "concept": "Bilateral gritty, sore eyes can be caused by dry eye syndrome",
        "concept_percentile": "63",
        "concept_colour": "rgb(188,255,0)",
        "number_attempts": "4341",
        "up_votes": "30",
        "down_votes": "31",
        "column_array": [
            0,
            "80",
            "2971",
            "387",
            "670",
            "233",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 4,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_2126",
        "new_question_id": "61207",
        "question_type": "0",
        "category": "10",
        "concept_id_link": "11040",
        "notes_id_link": "1_2443",
        "theme": "Indications for haemodialysis in acute kidney injury",
        "instruction": "",
        "options": [
            "",
            "Pulmonary oedema",
            "Hyperkalaemia",
            "Uraemia",
            "Metabolic acidosis",
            "Oliguria",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 68-year-old man with AKI becomes acutely dyspnoeic and hypoxic. He is oliguric with bibasal coarse crackles on auscultation, unresponsive to intravenous diuretics.<br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>K<sup>+</sup></td><td>6.2 mmol/L</td><td>(3.5 - 5.3)</td></tr><tr><td>Urea</td><td>38 mmol/L</td><td>(2.5 - 7.8)</td></tr><tr><td>Creatinine</td><td>490 \u00b5mol/L</td><td>(60 - 110)</td></tr><tr><td>Bicarbonate</td><td>16 mmol/L</td><td>(22 - 29)</td></tr></tbody></table></div>Select the single most pressing indication for haemodialysis from the options below.",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "The absolute indications for acute renal replacement therapy (RRT) can be remembered with the mnemonic AEIOU: Acidosis, Electrolyte abnormalities, Intoxication, Overload (fluid), and Uraemic symptoms. This patient has several abnormalities, but the most immediately life-threatening is the fluid overload causing respiratory compromise.<br /><br /><b>Pulmonary oedema</b> is the correct answer. This patient presents with acute dyspnoea, hypoxia (saturations of 89%), and widespread coarse crackles, which are classic signs of acute pulmonary oedema. This is a direct consequence of fluid overload from his oliguric acute kidney injury. Crucially, the scenario states he is unresponsive to intravenous diuretics, meaning medical management has failed. Diuretic-resistant pulmonary oedema is an absolute, emergency indication for RRT. Ultrafiltration via haemodialysis can rapidly remove excess fluid from the circulation, resolving the pulmonary oedema and improving gas exchange, thereby treating the most immediate threat to the patient's life.<br /><br /><b>Hyperkalaemia</b> is a potential indication for RRT, particularly if it is severe (typically >6.5 mmol/L), associated with ECG changes, or refractory to medical management. While this patient's potassium of 6.2 mmol/L is significantly elevated and requires urgent treatment (e.g., calcium gluconate, insulin/dextrose infusion), it is not as immediately life-threatening as the acute respiratory failure. Medical management is likely to be effective in the short term for this level of hyperkalaemia, whereas medical management for his pulmonary oedema has already failed.<br /><br /><b>Uraemia</b> itself, as defined by a high urea level, is not a direct indication for dialysis. The indication is the presence of severe uraemic complications, such as uraemic encephalopathy (characterised by confusion, drowsiness, or seizures) or uraemic pericarditis (presenting with pleuritic chest pain and a pericardial rub). The scenario does not provide any evidence of these complications. Therefore, while the urea level of 38 mmol/L is very high, it is not the most pressing reason for dialysis in this acutely hypoxic patient.<br /><br /><b>Metabolic acidosis</b>, indicated by the low bicarbonate level of 16 mmol/L, is a common complication of AKI. Severe metabolic acidosis (e.g., pH <7.1 or bicarbonate <15 mmol/L) that is refractory to treatment with intravenous sodium bicarbonate is an indication for RRT. However, this patient's level of acidosis is moderate and not as immediately life-threatening as his acute respiratory failure. The priority is to correct the hypoxia caused by the pulmonary oedema.<br /><br /><b>Oliguria</b> is a sign and a diagnostic criterion for acute kidney injury, not an indication for RRT in itself. It is the consequences of the kidney's inability to excrete fluid and waste products that lead to the indications for dialysis. In this case, the patient's oliguria has led to fluid overload and subsequent pulmonary oedema. Therefore, pulmonary oedema is the indication for treatment, while oliguria is part of the underlying pathophysiology.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 68-year-old man with AKI becomes acutely dyspnoeic and hypoxic. He is oliguric with bibasal coarse crackles on auscultation, unresponsive to intravenous diuretics.<br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>K<sup>+</sup></td><td>6.2 mmol/L</td><td>(3.5 - 5.3)</td></tr><tr><td>Urea</td><td>38 mmol/L</td><td>(2.5 - 7.8)</td></tr><tr><td>Creatinine</td><td>490 \u00b5mol/L</td><td>(60 - 110)</td></tr><tr><td>Bicarbonate</td><td>16 mmol/L</td><td>(22 - 29)</td></tr></tbody></table></div>Select the single most pressing indication for haemodialysis from the options below.",
        "correct_answer": "1",
        "question_notes": "The absolute indications for acute renal replacement therapy (RRT) can be remembered with the mnemonic AEIOU: Acidosis, Electrolyte abnormalities, Intoxication, Overload (fluid), and Uraemic symptoms. This patient has several abnormalities, but the most immediately life-threatening is the fluid overload causing respiratory compromise.<br /><br /><b>Pulmonary oedema</b> is the correct answer. This patient presents with acute dyspnoea, hypoxia (saturations of 89%), and widespread coarse crackles, which are classic signs of acute pulmonary oedema. This is a direct consequence of fluid overload from his oliguric acute kidney injury. Crucially, the scenario states he is unresponsive to intravenous diuretics, meaning medical management has failed. Diuretic-resistant pulmonary oedema is an absolute, emergency indication for RRT. Ultrafiltration via haemodialysis can rapidly remove excess fluid from the circulation, resolving the pulmonary oedema and improving gas exchange, thereby treating the most immediate threat to the patient's life.<br /><br /><b>Hyperkalaemia</b> is a potential indication for RRT, particularly if it is severe (typically >6.5 mmol/L), associated with ECG changes, or refractory to medical management. While this patient's potassium of 6.2 mmol/L is significantly elevated and requires urgent treatment (e.g., calcium gluconate, insulin/dextrose infusion), it is not as immediately life-threatening as the acute respiratory failure. Medical management is likely to be effective in the short term for this level of hyperkalaemia, whereas medical management for his pulmonary oedema has already failed.<br /><br /><b>Uraemia</b> itself, as defined by a high urea level, is not a direct indication for dialysis. The indication is the presence of severe uraemic complications, such as uraemic encephalopathy (characterised by confusion, drowsiness, or seizures) or uraemic pericarditis (presenting with pleuritic chest pain and a pericardial rub). The scenario does not provide any evidence of these complications. Therefore, while the urea level of 38 mmol/L is very high, it is not the most pressing reason for dialysis in this acutely hypoxic patient.<br /><br /><b>Metabolic acidosis</b>, indicated by the low bicarbonate level of 16 mmol/L, is a common complication of AKI. Severe metabolic acidosis (e.g., pH <7.1 or bicarbonate <15 mmol/L) that is refractory to treatment with intravenous sodium bicarbonate is an indication for RRT. However, this patient's level of acidosis is moderate and not as immediately life-threatening as his acute respiratory failure. The priority is to correct the hypoxia caused by the pulmonary oedema.<br /><br /><b>Oliguria</b> is a sign and a diagnostic criterion for acute kidney injury, not an indication for RRT in itself. It is the consequences of the kidney's inability to excrete fluid and waste products that lead to the indications for dialysis. In this case, the patient's oliguria has led to fluid overload and subsequent pulmonary oedema. Therefore, pulmonary oedema is the indication for treatment, while oliguria is part of the underlying pathophysiology.",
        "answer_order": "1",
        "answer": "1",
        "title": "Acute kidney injury: a very basic introduction",
        "body": "Acute kidney injury (AKI), previously termed acute renal failure, describes a reduction in renal function following an insult to the kidneys. In years gone by the kidneys were very much a neglected organ in acute medicine - the recognition of decreasing renal function was often slow and action limited. Around 15% of patients admitted to hospital develop AKI. <br /><br />Whilst most patients with AKI recover their renal function there are many patients who will have long term impaired kidney function due to AKI. As well as long-term morbidity, AKI may also result in acute complications including death. Whilst exact figures are difficult to calculate NICE estimate that inpatient mortality of AKI in the UK might typically be 25-30% or more.<br /><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb092b.jpg\" data-fancybox=\"gallery\" data-caption=\"Specimen from a patient who had an acute kidney injury. Note the marked pallor of the cortex in certain areas, contrasting to the darker areas of surviving medullary tissue. e Image used on license from PathoPic\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb092.jpg\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>What causes AKI?</h5><br />Causes of AKI are traditionally divided into prerenal, intrinsic and postrenal causes<br /><br /><h5 class='notes-heading'>Prerenal</h5><br />Think of what causes big problems in other major organs. In the heart, a lack of blood flow (ischaemia) to the myocardium causes a myocardial infarction. In a similar fashion, 85% of strokes are caused by ischaemia to the brain. The same goes for the kidneys. One of the major causes of AKI is ischaemia, or lack of blood flowing to the kidneys. <br /><br />Examples<br /><ul><li>hypovolaemia secondary to diarrhoea/vomiting</li><li>renal artery stenosis</li></ul><br /><h5 class='notes-heading'>Intrinsic</h5><br />The second group of causes relate to intrinsic damage to the glomeruli, renal tubules or interstitium of the kidneys themselves. This may be due to toxins (drugs, contrast etc) or immune-mediated glomuleronephritis.<br /><br />Examples<br /><ul><li>glomerulonephritis</li><li>acute tubular necrosis (ATN)</li><li>acute interstitial nephritis (AIN), respectively</li><li>rhabdomyolysis</li><li>tumour lysis syndrome</li></ul><br /><h5 class='notes-heading'>Postrenal</h5><br />The third group relates to problems after the kidneys. This is where there is an obstruction to the urine coming from the kidneys resulting in things 'backing-up' and affecting the normal renal function. An example could be a unilateral ureteric stone or bilateral hydroneprosis secondary to acute urinary retention caused by benign prostatic hyperplasia.<br /><br />Examples<br /><ul><li>kidney stone in ureter or bladder</li><li>benign prostatic hyperplasia</li><li>external compression of the ureter</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb093b.jpg\" data-fancybox=\"gallery\" data-caption=\"This patient had an invasive papillary tumour of the distal left ureter, indicated by the arrow. This resulted in the ureter becoming blocked, resulting in a left hydroureter and hydronephrosis. Note the thinning of the renal cortex of the left kidney compared to the right. e Image used on license from PathoPic\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb093.jpg\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Who is at an increased risk of AKI?</h5><br />One of the keys to reducing the incidence of AKI is identifying patient who are at increased risk. NICE support this approach and have published guidelines suggesting which patients are at greater risk. <br /><br />Risk factors for AKI include:<br /><ul><li>chronic kidney disease</li><li>other organ failure/chronic disease e.g. heart failure, liver disease, diabetes mellitus</li><li>history of acute kidney injury</li><li>use of drugs with nephrotoxic potential (e.g. <span class=\"concept\" data-cid=\"6907\">NSAIDs</span>, <span class=\"concept\" data-cid=\"6908\">aminoglycosides</span>, <span class=\"concept\" data-cid=\"6909\">ACE inhibitors</span>, <span class=\"concept\" data-cid=\"6910\">angiotensin II receptor antagonists</span> [ARBs] and <span class=\"concept\" data-cid=\"6911\">diuretics</span>) within the past week</li><li>use of iodinated contrast agents within the past week</li><li>age 65 years or over</li></ul>oliguria (urine output less than 0.5 ml/kg/hour)<br /><ul><li>neurological or cognitive impairment or disability, which may mean limited access to fluids because of reliance on a carer</li></ul><br /><br /><h5 class='notes-heading'>Preventing AKI</h5><br />By identifying patients at increased risk of AKI (see above) it may be possible to take steps to reduce the risk. For example, patients who are at risk of AKI and who are undergoing an investigation requiring contrast are usually given IV fluids to reduce the risk. Certain drugs such as ACE inhibitors and ARBs may also be temporarily stopped.<br /><br /><br /><h5 class='notes-heading'>What happens when kidneys stop working?</h5><br />It's best to work backwards and think about what kidneys actually do. The kidneys are primarily responsible for fluid balance and maintaining homeostasis. Therefore two of the key ways AKI may be detected are:<br /><ul><li>a reduced urine output. This is termed oliguria and is defined as a <span class=\"concept\" data-cid=\"1964\">urine output of less than 0.5 ml/kg/hour</span></li><li>fluid overload</li><li>a rise in molecules that the kidney normal excretes/maintains a careful balance of. Examples include potassium, urea and creatinine</li></ul><br /><br /><h5 class='notes-heading'>Symptoms and signs</h5><br />Many patients with early AKI may experience no symptoms. However, as renal failure progresses the following may be seen:<br /><ul><li>reduced urine output</li><li>pulmonary and peripheral oedema</li><li>arrhythmias (secondary to changes in potassium and acid-base balance)</li><li>features of uraemia (for example, pericarditis or encephalopathy)</li></ul><br /><br /><h5 class='notes-heading'>Detection</h5><br />One of the most common blood tests performed on the wards is 'urea and electrolytes' or 'U&Es'. This returns a number of markers, including<br /><ul><li>sodium</li><li>potassium</li><li>urea</li><li>creatinine</li></ul><br />NICE recommend that we can use a variety of different criteria to make an official diagnosis of AKI. They state:<br /><br /><div class='bs-callout bs-callout-default'><i><i><br />Detect acute kidney injury, in line with the (p)RIFLE, AKIN or KDIGO definitions, by using any of the following criteria:<br /><ul><li>a rise in serum creatinine of 26 micromol/litre or greater within 48 hours</li><li>a 50% or greater rise in serum creatinine known or presumed to have occurred within the past 7 days</li><li>a fall in urine output to <span class=\"concept\" data-cid=\"1964\">less than 0.5 ml/kg/hour</span> for more than 6 hours in adults and more than </li></ul></i></i></div><br />Urinalysis<br /><ul><li>all patients with suspected AKI should have urinalysis</li></ul><br />Imaging<br /><ul><li>if patients have no identifiable cause for the deterioration or are at risk of urinary tract obstruction they should have a <b>renal ultrasound</b> within 24 hours of assessment.</li></ul><br /><br /><h5 class='notes-heading'>Management</h5><br />The management of AKI is largely supportive. This means patients require careful fluid balance to ensure that the kidneys are properly perfused but not excessively to avoid fluid overload. It is also important to <span class=\"concept\" data-cid=\"4196\"> review a patient's medication list</span> to see what treatments may either be exacerbating their renal dysfunction or may be dangerous as a consequence of renal dysfunction. The table below gives some examples of common drugs:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Usually safe to continue in AKI</th><th>Should be stopped in AKI as may worsen renal function</th><th>May have to be stopped in AKI as increased risk of toxicity (but doesn't usually worsen AKI itself)</th></tr></thead><tbody><tr><td>&#8226; <span class=\"concept\" data-cid=\"6901\">Paracetamol</span><br />&#8226; <span class=\"concept\" data-cid=\"6902\">Warfarin</span> <br />&#8226; <span class=\"concept\" data-cid=\"6903\">Statins</span><br />&#8226; <span class=\"concept\" data-cid=\"6904\">Aspirin (at a cardioprotective dose of 75mg od)</span><br />&#8226; <span class=\"concept\" data-cid=\"6905\">Clopidogrel</span><br />&#8226; <span class=\"concept\" data-cid=\"6906\">Beta-blockers</span></td><td>&#8226; <span class=\"concept\" data-cid=\"6907\">NSAIDs</span> (<span class=\"concept\" data-cid=\"2070\">except if aspirin at cardiac dose e.g. 75mg od</span>)<br />&#8226; <span class=\"concept\" data-cid=\"6908\">Aminoglycosides</span><br />&#8226; <span class=\"concept\" data-cid=\"6909\">ACE inhibitors</span><br />&#8226; <span class=\"concept\" data-cid=\"6910\">Angiotensin II receptor antagonists</span><br />&#8226; <span class=\"concept\" data-cid=\"6911\">Diuretics</span><br /></td><td>&#8226; <span class=\"concept\" data-cid=\"6912\">Metformin</span><br />&#8226; <span class=\"concept\" data-cid=\"6913\">Lithium</span><br />&#8226; <span class=\"concept\" data-cid=\"6914\">Digoxin</span></td></tr></tbody></table></div><br />Treatments which are <b>not recommend</b> include the routine use of loop diuretics (to artificially boost urine output) and low-dose dopamine (in an attempt to increase renal perfusion). There is however a role for loop diuretics in patients who experience significant fluid overload.<br /><br />Hyperkalaemia also needs prompt treatment to avoid arrhythmias which may potentially be life-threatening. The table below categorises the different treatments for hyperkalaemia:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th>Stabilisation of the cardiac membrane</th><th>&#8226; Short-term shift in potassium from extracellular to intracellular fluid compartment</th><th>&#8226; Removal of potassium from the body</th></tr></thead><tbody><tr><td>&#8226; <span class=\"concept\" data-cid=\"6915\">Intravenous calcium gluconate</span></td><td>&#8226; <span class=\"concept\" data-cid=\"6916\">Combined insulin/dextrose infusion</span><br />&#8226; <span class=\"concept\" data-cid=\"6917\">Nebulised salbutamol</span><br /></td><td>&#8226; <span class=\"concept\" data-cid=\"6918\">Calcium resonium (orally or enema)</span><br />&#8226; <span class=\"concept\" data-cid=\"6919\">Loop diuretics</span><br />&#8226; <span class=\"concept\" data-cid=\"6920\">Dialysis</span></td></tr></tbody></table></div><br />Specialist input from a nephrologist is required for cases where the cause is not known or where the AKI is severe.<br /><br />All patients with suspected AKI secondary to urinary obstruction require prompt review by a urologist.<br /><br />Renal replacement therapy (e.g. haemodialysis) is used when a patient is not responding to medical treatment of complications, for example hyperkalaemia, <span class=\"concept\" data-cid=\"11040\">pulmonary oedema</span>, acidosis or <span class=\"concept\" data-cid=\"5746\">uraemia (e.g. pericarditis, encephalopathy)</span>.",
        "notes_hash": "2e255617a5feb490a53122427df3820c",
        "knowledge_graph_node_id_link": 10779,
        "concept": "Pulmonary oedema is an indication for haemodialysis in a patient with acute kidney injury",
        "concept_percentile": "40",
        "concept_colour": "rgb(255,204,0)",
        "number_attempts": "215",
        "up_votes": "3",
        "down_votes": "0",
        "column_array": [
            0,
            "67",
            "71",
            "48",
            "15",
            "14",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Think Kidneys </td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1151\" data-linkid=\"1151\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1151\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">35</span><button type=\"button\" style=\"\" id=\"link_dislike_1151\" data-linkid=\"1151\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1151\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">27</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.thinkkidneys.nhs.uk/aki/resources/junior-doctors/\">Resources for doctors</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/a/af/Prerenal_acute_kidney_injury.webm\" data-description=\"Prerenal acute kidney injury\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"229\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/a/af/Prerenal_acute_kidney_injury.webm\" data-description=\"Prerenal acute kidney injury\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"229\">Prerenal acute kidney injury</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1739\" data-mediaid=\"1739\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1739\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_1739\" data-mediaid=\"1739\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1739\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/5/59/Postrenal_acute_kidney_injury.webm\" data-description=\"Postrenal acute kidney injury\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"231\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/5/59/Postrenal_acute_kidney_injury.webm\" data-description=\"Postrenal acute kidney injury\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"231\">Postrenal acute kidney injury</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_378\" data-mediaid=\"378\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_378\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_378\" data-mediaid=\"378\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_378\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/0/00/Intrarenal_acute_kidney_injury.webm\" data-description=\"Intrarenal acute kidney injury\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"230\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/0/00/Intrarenal_acute_kidney_injury.webm\" data-description=\"Intrarenal acute kidney injury\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"230\">Intrarenal acute kidney injury</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1738\" data-mediaid=\"1738\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1738\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_1738\" data-mediaid=\"1738\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1738\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/MH1DCCqLGps\" data-description=\"Acute kidney injury\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1146\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/MH1DCCqLGps/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/MH1DCCqLGps\" data-description=\"Acute kidney injury\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1146\">Acute kidney injury</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1982\" data-mediaid=\"1982\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1982\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_1982\" data-mediaid=\"1982\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1982\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/as40yVd6Z8U\" data-description=\"Understanding Acute Kidney Injury (AKI Made Easy)\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1362\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/as40yVd6Z8U/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/as40yVd6Z8U\" data-description=\"Understanding Acute Kidney Injury (AKI Made Easy)\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1362\">Understanding Acute Kidney Injury (AKI Made Easy)</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2392\" data-mediaid=\"2392\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2392\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2392\" data-mediaid=\"2392\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2392\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "4196": {
                "concept_text": "Medications to stop when a patient is in acute kidney injury: ACE-I/ARB, NSAIDs and diuretics",
                "concept_percentile": "93"
            },
            "11040": {
                "concept_text": "Pulmonary oedema is an indication for haemodialysis in a patient with acute kidney injury",
                "concept_percentile": "40"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "16718_B_1165",
        "new_question_id": "35042",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "603",
        "notes_id_link": "1_269",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Amlodipine",
            "Bendroflumethiazide",
            "Diltiazem",
            "Irbesartan",
            "Spironolactone",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 63-year-old man presents to his general practitioner for a blood pressure check. Ambulatory blood pressure readings are constantly above 140/90 mmHg. His past medical history includes gout and types two diabetes mellitus, for which he takes metformin and allopurinol. He is of black African ethnicity. <br /><br />What drug is the most appropriate to prescribe him?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer is <b>irbesartan</b>. This medication is an angiotensin II receptor blocker (A2RB). It is used to manage hypertension in diabetic patients, as it has a renoprotective effect. <br /><br />Black African and Afro-Caribbean patients are prescribed calcium channel blockers first-line for hypertension. However, as the patient is diabetic, ACE inhibitors/A2RBs are preferred due to their renoprotective effect. In black African and Afro-Caribbean patients, A2RBs are preferred over ACE inhibitors. <br /><br /><b>Amlodipine</b> is a calcium channel blocker used as first-line management of patients > 55 years old or black African and Afro-Caribbean patients. However, as the patient is diabetic, ACE inhibitors and A2RBs take precedence, making this option incorrect. <br /><br /><b>Bendroflumethiazide</b> is a medication used as a second-line option in the management of hypertension. This patient has not trialled any first-line options yet, making the option incorrect. Additionally, these drugs are contraindicated in patients with gout. <br /><br /><b>Diltiazem</b> is a calcium channel blocker used as first-line management of patients > 55 years old or black African and Afro-Caribbean patients. However, as the patient is diabetic, ACE inhibitors and A2RBs take precedence, making this option incorrect. <br /><br /><b>Spironolactone</b> is a potassium-sparing diuretic that can be used in the management of hypertension when a triple combination of drugs has failed and if the potassium is < 4.5 mmol/L. This patient has not trialled any first-line options yet, making this option incorrect.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 63-year-old man presents to his general practitioner for a blood pressure check. Ambulatory blood pressure readings are constantly above 140/90 mmHg. His past medical history includes gout and types two diabetes mellitus, for which he takes metformin and allopurinol. He is of black African ethnicity. <br /><br />What drug is the most appropriate to prescribe him?",
        "correct_answer": "4",
        "question_notes": "The correct answer is <b>irbesartan</b>. This medication is an angiotensin II receptor blocker (A2RB). It is used to manage hypertension in diabetic patients, as it has a renoprotective effect. <br /><br />Black African and Afro-Caribbean patients are prescribed calcium channel blockers first-line for hypertension. However, as the patient is diabetic, ACE inhibitors/A2RBs are preferred due to their renoprotective effect. In black African and Afro-Caribbean patients, A2RBs are preferred over ACE inhibitors. <br /><br /><b>Amlodipine</b> is a calcium channel blocker used as first-line management of patients > 55 years old or black African and Afro-Caribbean patients. However, as the patient is diabetic, ACE inhibitors and A2RBs take precedence, making this option incorrect. <br /><br /><b>Bendroflumethiazide</b> is a medication used as a second-line option in the management of hypertension. This patient has not trialled any first-line options yet, making the option incorrect. Additionally, these drugs are contraindicated in patients with gout. <br /><br /><b>Diltiazem</b> is a calcium channel blocker used as first-line management of patients > 55 years old or black African and Afro-Caribbean patients. However, as the patient is diabetic, ACE inhibitors and A2RBs take precedence, making this option incorrect. <br /><br /><b>Spironolactone</b> is a potassium-sparing diuretic that can be used in the management of hypertension when a triple combination of drugs has failed and if the potassium is < 4.5 mmol/L. This patient has not trialled any first-line options yet, making this option incorrect.",
        "answer_order": "4",
        "answer": "4",
        "title": "Diabetes mellitus: hypertension management",
        "body": "Patient with diabetes mellitus have traditionally had their blood pressure controlled more aggressively to help reduce their overall cardiovascular risk. However, a 2013 Cochrane review cast doubt on the wisdom of lower blood pressure targets for patients with diabetes. It compared patients who had tight blood pressure control (targets < 130/85 mmHg) with more relaxed control (< 140-160/90-100 mmHg). Patients who were more tightly controlled had a slightly reduced rate of stroke but otherwise, outcomes were not significantly different.<br /><br />In light of this, NICE recommends a <span class=\"concept\" data-cid=\"604\">blood pressure target of < 140/90 mmHg for type 2 diabetics</span>, the same as for patients without diabetes.<br /><br />For patients with type 1 diabetes, NICE recommends:<br /><br /><div class='bs-callout bs-callout-default'><i><br />Intervention levels for recommending blood pressure management should be <span class=\"concept\" data-cid=\"10779\">135/85 mmHg</span> unless the adult with type 1 diabetes has albuminuria or 2 or more features of metabolic syndrome, in which case it should be 130/80 mmHg<br /></i></div><br />Because <span class=\"concept\" data-cid=\"603\">ACE inhibitors/or angiotensin-II receptor antagonist (A2RBs)</span> have a renoprotective effect in diabetes they are the first-line antihypertensive regardless of age. A2RBs are preferred for black African or African-Caribbean diabetic patients. Further management then reverts to that of non-diabetic patients.<br /><br />Remember that autonomic neuropathy may result in more postural symptoms in patients taking antihypertensive therapy.<br /><br />The routine use of beta-blockers in uncomplicated hypertension should be avoided, particularly when given in combination with thiazides, as they may cause insulin resistance, impair insulin secretion and alter the autonomic response to hypoglycaemia.",
        "notes_hash": "ab49ae44665f6e7947630f3ed4154374",
        "knowledge_graph_node_id_link": 10924,
        "concept": "Hypertension in diabetics - ACE inhibitors/A2RBs are first-line regardless of age",
        "concept_percentile": "56",
        "concept_colour": "rgb(224,255,0)",
        "number_attempts": "5923",
        "up_votes": "51",
        "down_votes": "30",
        "column_array": [
            0,
            "3060",
            "50",
            "114",
            "2678",
            "21",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1486\" data-linkid=\"1486\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1486\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"link_dislike_1486\" data-linkid=\"1486\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1486\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng136/chapter/Recommendations\">2019 Hypertension guidelines</a></td></tr></table>",
        "media": "",
        "comment_count": 3,
        "concepts_for_notes": {
            "603": {
                "concept_text": "Hypertension in diabetics - ACE inhibitors/A2RBs are first-line regardless of age",
                "concept_percentile": "56"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_149",
        "new_question_id": "7550",
        "question_type": "1",
        "category": "9",
        "concept_id_link": "0",
        "notes_id_link": "1_2550",
        "theme": "Limb examination findings",
        "instruction": "Select the most likely positive examination finding for the following clinical scenarios. Each option can be chosen once, more than once or not at all. ",
        "options": [
            "",
            "Kernigs sign",
            "Ankle Brachial Pressure Index",
            "Tinels test ",
            "Straight leg raise",
            "Tongue fasciculations",
            "Hoffmans sign",
            "Limited external rotation of the shoulder",
            "Hypothenar wasting",
            "Limited internal rotation of the shoulder",
            ""
        ],
        "num_of_options": 9,
        "questions": [
            "A 70 year-old male with a background of diabetes and hypertension presents with pain and weakness in both legs on walking. It settles with rest. ",
            "M 54 kqmd-axp rqymxq oaybxmuze ar dustf tmzp bmuz dmpumfuzs uzfa tqd ftgyn, uzpqj mzp yuppxq ruzsqd. Uf arfqz imwqe tqd gb rday exqqb.",
            "M 65 kqmd-axp rqymxq bdqeqzfe iuft m xaee ar pqjfqdufk uz naft tmzpe. Etq tme nqqz efdgssxuzs fa fkbq mf iadw mzp geq tqd yanuxq btazq. Tqd ekybfaye tmhq nqqz pqfqduadmfuzs sdmpgmxxk ahqd ftq bdqoqpuzs yazfte."
        ],
        "answers": [
            "2",
            "3",
            "6"
        ],
        "notes": [
            "This patient is likely to have peripheral vascular disease [PVD] given his background risk factors for this condition. The ankle brachial pressure index [ABPI] is a simple method of assessing the peripheral circulation. It is calculated by dividing systolic blood pressure in the ankle by the the systolic blood pressure in the arm. These are equal in health (ABPI = 1). The ABPI is reduced in PVD.",
            "This patient is likely to have carpal tunnel syndrome. This occurs due to median nerve entrapment beneath the flexor retinaculum. Clinical tests to raise carpal tunnel pressure can exacerbate symptoms and support a diagnosis. One such example is Tinels test, includes tapping over the volar surface of the wrist joint i.e. over the carpal tunnel, may reproduce paraesthesias. A normal Tinels test does not exclude carpal tunnel syndrome.",
            "This patient is likely to have degenerative cervical myelopathy [DCM], which is associated with upper motor neuron signs. Hoffmans sign is elicited by flicking the distal phalaynx of the middle finger to cause momentary flexion. A positive result is exaggerated flexion of the terminal phalanyx of the thumb. Patients with DCM often have subtle signs that are easily missed [1], but as a progressive condition, these are likely to get worse [2]. Whilst the sensitivity of signs is low (i.e. their absence does not rule out a problem), their specificity is high (i.e. there will be a problem). Therefore, in order to diagnose early DCM and improve patient outcomes, a high index of suspicion, alongside a comprehensive neurological examination and monitoring for progression is required. <br /><br />Other signs mentioned: <br /><ul><li>Kernigs sign refers to painful knee extension, from a position of hip flexion and knee flexion. It suggest meningeal irritation e.g. meningitis, subarachnoid haemorrhage. </li><li>Straight leg raise: this is positively associated with radicular pathology such as disc herniation. The patient feels pain in the back when the leg is raised between 30-60 degrees. </li><li>Limited external rotation is classically found in adhesive capsulitis. Patients have global restriction of shoulder movements, in at least two axes, though external rotation is usually the most affected and painful.</li></ul><br />References: <br />1. Behrbalk E, Salame K, Regev GJ, Keynan O, Boszczyk B, Lidar Z. Delayed diagnosis of cervical spondylotic myelopathy by primary care physicians. Neurosurg Focus. 2013 Jul;35(1):E1.<br />2. Baron EM, Young WF. Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery. 2007 Jan;60(1 Supp1 1):S35-41.<br />"
        ],
        "exam_specific_explanation": "",
        "question": "A 70 year-old male with a background of diabetes and hypertension presents with pain and weakness in both legs on walking. It settles with rest. ",
        "correct_answer": "2",
        "question_notes": "This patient is likely to have peripheral vascular disease [PVD] given his background risk factors for this condition. The ankle brachial pressure index [ABPI] is a simple method of assessing the peripheral circulation. It is calculated by dividing systolic blood pressure in the ankle by the the systolic blood pressure in the arm. These are equal in health (ABPI = 1). The ABPI is reduced in PVD.",
        "answer_order": "2",
        "answer": "2",
        "title": "Degenerative cervical myelopathy",
        "body": "Degenerative cervical myelopathy (DCM) has a number of risk factors, which include smoking due to its effects on the intervertebral discs, genetics and occupation - those exposing patients to high axial loading [1]. <br /><br />The presentation of DCM is very variable. Early symptoms are often subtle and can vary in severity day to day, making the disease difficult to detect initially. However as a progressive condition, worsening, deteriorating or new symptoms should be a warning sign.<br /><br />DCM symptoms can include any combination of [1]: <br /><ul><li>Pain (affecting the neck, upper or lower limbs)</li><li>Loss of motor function (loss of digital dexterity, preventing simple tasks such as holding a fork or doing up their shirt buttons, arm or leg weakness/stiffness leading to impaired gait and imbalance</li><li>Loss of sensory function causing numbness</li><li>Loss of autonomic function (urinary or faecal incontinence and/or impotence) - these can occur and do not necessarily suggest cauda equina syndrome in the absence of other hallmarks of that condition</li><li>Hoffman's sign: is a reflex test to assess for cervical myelopathy. It is performed by gently flicking one finger on a patient's hand. A positive test results in reflex twitching of the other fingers on the same hand in response to the flick. </li></ul><br />The most common symptoms at presentation of DCM are unknown, but in one series 50% of patients were initially incorrectly diagnosed and sometimes treated for carpal tunnel syndrome [2].<br /><br />An MRI of the cervical spine is the gold standard test where cervical myelopathy is suspected. It may reveal disc degeneration and ligament hypertrophy, with accompanying cord signal change.<br /><br />All patients with degenerative cervical myelopathy should be urgently referred for assessment by specialist spinal services (neurosurgery or orthopaedic spinal surgery). This is due to the importance of early treatment. The timing of surgery is important, as any existing spinal cord damage can be permanent. Early treatment (within 6 months of diagnosis) offers the best chance of a full recovery but at present, most patients are presenting too late. In one study, patients averaged over 5 appointments before diagnosis, representing >2 years. <br /><br />Currently, decompressive surgery is the only effective treatment. It has been shown to prevent disease progression. Close observation is an option for mild stable disease, but anything progressive or more severe requires surgery to prevent further deterioration. Physiotherapy should only be initiated by specialist services, as manipulation can cause more spinal cord damage. <br /><br />References<br />1. Baron EM, Young WF. Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery. 2007 Jan;60(1 Supp1 1):S35-41.<br />2. Behrbalk E, Salame K, Regev GJ, Keynan O, Boszczyk B, Lidar Z. Delayed diagnosis of cervical spondylotic myelopathy by primary care physicians. Neurosurg Focus. 2013 Jul;35(1):E1.",
        "notes_hash": "7ef7736b1e8f10c4795c45507825b99b",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4309",
        "up_votes": "21",
        "down_votes": "28",
        "column_array": [
            0,
            "3385",
            "3716",
            "2655",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/xfguBiqsoDk\" data-description=\"MS with positive Hoffman's sign and Babinski test\" data-upvotes=\"38\" data-downvotes=\"4\" data-media=\"444\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/xfguBiqsoDk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/xfguBiqsoDk\" data-description=\"MS with positive Hoffman's sign and Babinski test\" data-upvotes=\"38\" data-downvotes=\"4\" data-media=\"444\">MS with positive Hoffman's sign and Babinski test</a></td></tr><tr><td><span ><small>Individual - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1322\" data-mediaid=\"1322\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1322\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">38</span><button type=\"button\" style=\"\" id=\"media_dislike_1322\" data-mediaid=\"1322\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1322\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/uVI55amnVuk\" data-description=\"Hoffmann's Sign or Reflex - Upper Motor Neuron Lesion\" data-upvotes=\"7\" data-downvotes=\"3\" data-media=\"756\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/uVI55amnVuk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/uVI55amnVuk\" data-description=\"Hoffmann's Sign or Reflex - Upper Motor Neuron Lesion\" data-upvotes=\"7\" data-downvotes=\"3\" data-media=\"756\">Hoffmann's Sign or Reflex - Upper Motor Neuron Lesion</a></td></tr><tr><td><span ><small>Physiotutors - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1323\" data-mediaid=\"1323\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1323\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"media_dislike_1323\" data-mediaid=\"1323\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1323\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2023",
        "new_question_id": "6326",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "0",
        "notes_id_link": "1_2066",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Vitamin A",
            "Vitamin B1",
            "Vitamin B12",
            "Vitamin C",
            "Vitamin D",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 32 year old lady with no underlying co-morbidities presents as she has found she is pregnant.  You counsel her about pregnancy supplements.  She asks if she can just continue her usual multivitamin tablet she buys over the counter.  Which vitamin, if taken in high doses, can be teratogenic?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "Vitamin A is teratogenic in high doses, and pregnant women should not exceed a daily intake of >10,000IU.  Women are therefore advised to avoid any supplements containing vitamin A, such as normal multivitamin tablets, in pregnancy (NHS Choices).  However, as supplements in the UK are now limited to a maximum vitamin A content of 6,000IU, if they have been taking one it should not be cause for concern. Pregnant women are also advised to avoid eating liver, as it has high levels of vitamin A. ",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 32 year old lady with no underlying co-morbidities presents as she has found she is pregnant.  You counsel her about pregnancy supplements.  She asks if she can just continue her usual multivitamin tablet she buys over the counter.  Which vitamin, if taken in high doses, can be teratogenic?",
        "correct_answer": "1",
        "question_notes": "Vitamin A is teratogenic in high doses, and pregnant women should not exceed a daily intake of >10,000IU.  Women are therefore advised to avoid any supplements containing vitamin A, such as normal multivitamin tablets, in pregnancy (NHS Choices).  However, as supplements in the UK are now limited to a maximum vitamin A content of 6,000IU, if they have been taking one it should not be cause for concern. Pregnant women are also advised to avoid eating liver, as it has high levels of vitamin A. ",
        "answer_order": "1",
        "answer": "1",
        "title": "Vitamin A (retinol)",
        "body": "Vitamin A is a fat soluble vitamin. <br /><br />Functions<br /><ul><li>converted into retinal, an important visual pigment</li><li>important in epithelial cell differentiation</li><li>antioxidant</li></ul><br />Consequences of vitamin A deficiency<br /><ul><li>night blindness</li></ul>",
        "notes_hash": "e5fc2593b4280498ca546ea41069fa98",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6484",
        "up_votes": "38",
        "down_votes": "11",
        "column_array": [
            0,
            "5268",
            "417",
            "352",
            "198",
            "249",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 2,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_4203",
        "new_question_id": "11908",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "1216",
        "notes_id_link": "1_2592",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Arrange a full blood count on the paediatric ward within the next 2 days",
            "Reassure petechiae are commonly seen with viral illnesses",
            "Sensitively ask about the possibility of non-accidental injury",
            "Prescribe an emollient",
            "Admit immediately to paediatrics",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 4-year-old girl is brought to surgery by her mother who has noticed a number of small 'spots' and 'bruises' on her legs that have developed over the past 2-3 days. She initially thought this was due to an allergy but it has not gone away. Her daughter is described as being well apart from a cough she's had for the past 2 weeks.<br /><br />On examination, she is apyrexial with a heart rate of 96/min. Examination of her ears, throat and chest is normal. There is no neck stiffness or abdominal masses. A number of petechiae are seen around her chest area as well as purpura on her lower legs and arms.<br /><br />What is the most appropriate action?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "Whilst petechiae can be seen in a viral illness or with increased superior vena cava pressure (e.g. following a cough) purpura are never a normal finding in children. She needs to be immediately admitted to exclude a serious underlying condition.<br /><br />If there is any suspicion of meningococcal septicaemia (not present in this case) parenteral antibiotics should be given, as long as this doesn't delay transfer.<br />",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 4-year-old girl is brought to surgery by her mother who has noticed a number of small 'spots' and 'bruises' on her legs that have developed over the past 2-3 days. She initially thought this was due to an allergy but it has not gone away. Her daughter is described as being well apart from a cough she's had for the past 2 weeks.<br /><br />On examination, she is apyrexial with a heart rate of 96/min. Examination of her ears, throat and chest is normal. There is no neck stiffness or abdominal masses. A number of petechiae are seen around her chest area as well as purpura on her lower legs and arms.<br /><br />What is the most appropriate action?",
        "correct_answer": "5",
        "question_notes": "Whilst petechiae can be seen in a viral illness or with increased superior vena cava pressure (e.g. following a cough) purpura are never a normal finding in children. She needs to be immediately admitted to exclude a serious underlying condition.<br /><br />If there is any suspicion of meningococcal septicaemia (not present in this case) parenteral antibiotics should be given, as long as this doesn't delay transfer.<br />",
        "answer_order": "5",
        "answer": "5",
        "title": "Purpura",
        "body": "Purpura describes bleeding into the skin from small blood vessels that produces a non-blanching rash. Smaller petechiae (1-2 mm in diameter) may also be seen. It is typically caused by low platelets but may also be seen with bleeding disorders, such as von Willebrand disease.<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb302b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb302.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>Image sourced from </span><a href='https://en.wikipedia.org/wiki/Main_Page'  target='_blank' style = 'font-size:11px; color:LightGray;' >Wikipedia</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb302b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Purpuric rash secondary to medication-induced vasculitis</div><br />It is important to recognise purpura as it can indicate the presence of serious underlying disease. Children with a new purpuric rash should be admitted immediately for investigations as it may be a sign of <b>meningococcal septicaemia or acute lymphoblastic leukaemia</b>. Parenteral antibiotics should be given prior to transfer if meningococcal septicaemia is suspected.<br /><br /><h5 class='notes-heading'>Causes</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Children</th><th>Adults</th></tr></thead><tbody><tr><td>&#8226; Meningococcal septicaemia<br />&#8226; Acute lymphoblastic leukaemia<br /><br />&#8226; Congenital bleeding disorders<br />&#8226; Immune thrombocytopenic purpura<br />&#8226; Henoch-Schonlein purpura<br />&#8226; Non-accidental injury</td><td>&#8226; Immune thrombocytopenic purpura<br />&#8226; Bone marrow failure (secondary to leukaemias, myelodysplasia or bone metastases)<br />&#8226; Senile purpura<br />&#8226; Drugs (quinine, antiepileptics, antithrombotics)<br />&#8226; Nutritional deficiencies (vitamins B12, C and folate)</td></tr></tbody></table></div><br />Raised superior vena cava pressure (e.g. secondary to a bad cough) may cause petechiae in the upper body but would not cause purpura.",
        "notes_hash": "62160741ca26e09236ca9061a37ed09d",
        "knowledge_graph_node_id_link": 0,
        "concept": "Children with new-onset purpura should be referred immediately for investigations to exclude ALL and meningococcal disease",
        "concept_percentile": "88",
        "concept_colour": "rgb(61,255,0)",
        "number_attempts": "7308",
        "up_votes": "54",
        "down_votes": "52",
        "column_array": [
            0,
            "1960",
            "1262",
            "231",
            "75",
            "3780",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 8,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "4370_B_60",
        "new_question_id": "16730",
        "question_type": "0",
        "category": "6",
        "concept_id_link": "2665",
        "notes_id_link": "1_774",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Heberden's nodes",
            "Bouchard's nodes",
            "Osler nodes",
            "Gottron's papules",
            "Janeway lesions",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "You are a foundation doctor working in general practice. You review a thirty-two-year-old lady with muscle weakness and erythematous, keratotic macules overlying her interphalangeal joints.<br /><br />She has a family history of osteoarthritis.<br /><br />Which of the following describes the changes on her hands?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "This patient may have dermatomyositis. She is describing muscle weakness with associated skin changes. Gottron's papules are erythematous, keratotic macules overlying her interphalangeal joints and they are seen in dermatomyositis.<br /><br />It is osteoarthritis that is linked to Bouchard's and Heberden's nodes. They present as painless swellings of the proximal and distal interphalangeal joints respectively. <br /><br />Osler nodes and janeway lesions are associated with endocarditis and present as macular lesions on the palms. Osler nodes are painful and due to immune complex deposition whereas janeway lesions are painless and due to septic emboli.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "You are a foundation doctor working in general practice. You review a thirty-two-year-old lady with muscle weakness and erythematous, keratotic macules overlying her interphalangeal joints.<br /><br />She has a family history of osteoarthritis.<br /><br />Which of the following describes the changes on her hands?",
        "correct_answer": "4",
        "question_notes": "This patient may have dermatomyositis. She is describing muscle weakness with associated skin changes. Gottron's papules are erythematous, keratotic macules overlying her interphalangeal joints and they are seen in dermatomyositis.<br /><br />It is osteoarthritis that is linked to Bouchard's and Heberden's nodes. They present as painless swellings of the proximal and distal interphalangeal joints respectively. <br /><br />Osler nodes and janeway lesions are associated with endocarditis and present as macular lesions on the palms. Osler nodes are painful and due to immune complex deposition whereas janeway lesions are painless and due to septic emboli.",
        "answer_order": "4",
        "answer": "4",
        "title": "Dermatomyositis",
        "body": "Overview<br /><ul><li>an inflammatory disorder causing symmetrical, proximal muscle weakness and characteristic skin lesions</li><li>may be idiopathic or associated with connective tissue disorders or <span class=\"concept\" data-cid=\"2709\">underlying malignancy</span> (typically ovarian, breast and lung cancer, found in 20-25% - more if patient older). <span class=\"concept\" data-cid=\"4160\">Screening for an underlying malignancy</span> is usually performed following a diagnosis of dermatomyositis</li><li>polymyositis is a variant of the disease where skin manifestations are not prominent</li></ul><br />Skin features<br /><ul><li>photosensitive</li><li>macular rash over back and shoulder</li><li>heliotrope rash in the periorbital region</li><li><span class=\"concept\" data-cid=\"2665\">Gottron's papules - roughened red papules over extensor surfaces of fingers</span></li><li> 'mechanic's hands': extremely dry and scaly hands with linear 'cracks' on the palmar and lateral aspects of the fingers</li><li>nail fold capillary dilatation</li></ul><br />Other features<br /><ul><li>proximal muscle weakness +/- tenderness</li><li>Raynaud's</li><li>respiratory muscle weakness</li><li>interstitial lung disease: e.g. Fibrosing alveolitis or organising pneumonia</li><li>dysphagia, dysphonia</li></ul><br />Investigations<br /><ul><li>the majority of patients (around 80%) are ANA positive</li><li>around 30% of patients have antibodies to aminoacyl-tRNA synthetases (anti-synthetase antibodies), including:<ul><li><span class=\"concept\" data-cid=\"9286\">antibodies against histidine-tRNA ligase (also called Jo-1)</span></li><li>antibodies to signal recognition particle (SRP)</li><li>anti-Mi-2 antibodies</li></ul></li></ul>",
        "notes_hash": "b4954774d646eebc091d256ac2500f83",
        "knowledge_graph_node_id_link": 1416,
        "concept": "Gottron's papules, roughened red papules over the knuckles mainly, are seen in dermatomyositis <br />",
        "concept_percentile": "73",
        "concept_colour": "rgb(137,255,0)",
        "number_attempts": "4372",
        "up_votes": "32",
        "down_votes": "53",
        "column_array": [
            0,
            "777",
            "674",
            "313",
            "2466",
            "142",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2030\" data-linkid=\"2030\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2030\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">24</span><button type=\"button\" style=\"\" id=\"link_dislike_2030\" data-linkid=\"2030\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2030\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">15</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://dermnetnz.org/topics/adult-onset-dermatomyositis/\">Dermatomyositis</a></td></tr></table><br><br><table style='width:100%'><tr><td>Primary Care Dermatology Society</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2031\" data-linkid=\"2031\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2031\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"link_dislike_2031\" data-linkid=\"2031\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2031\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.pcds.org.uk/clinical-guidance/dermatomyositis\">Dermatomyositis (including polymyositis)</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cZbj0EhOFQI\" data-description=\"Polymyositis and Dermatomyositis in 3 Minutes\" data-upvotes=\"39\" data-downvotes=\"3\" data-media=\"1395\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/cZbj0EhOFQI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cZbj0EhOFQI\" data-description=\"Polymyositis and Dermatomyositis in 3 Minutes\" data-upvotes=\"39\" data-downvotes=\"3\" data-media=\"1395\">Polymyositis and Dermatomyositis in 3 Minutes</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2457\" data-mediaid=\"2457\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2457\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">39</span><button type=\"button\" style=\"\" id=\"media_dislike_2457\" data-mediaid=\"2457\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2457\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/FGAEw97Etb4\" data-description=\"Understanding Myositis (Polymyositis and Dermatomyositis)\" data-upvotes=\"5\" data-downvotes=\"5\" data-media=\"1498\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/FGAEw97Etb4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/FGAEw97Etb4\" data-description=\"Understanding Myositis (Polymyositis and Dermatomyositis)\" data-upvotes=\"5\" data-downvotes=\"5\" data-media=\"1498\">Understanding Myositis (Polymyositis and Dermatomyositis)</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2637\" data-mediaid=\"2637\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2637\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_2637\" data-mediaid=\"2637\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2637\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ekRZkjTlgro\" data-description=\"Dermatomyositis Overview\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"1554\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ekRZkjTlgro/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ekRZkjTlgro\" data-description=\"Dermatomyositis Overview\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"1554\">Dermatomyositis Overview</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2708\" data-mediaid=\"2708\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2708\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2708\" data-mediaid=\"2708\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2708\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": {
            "2665": {
                "concept_text": "Gottron's papules, roughened red papules over the knuckles mainly, are seen in dermatomyositis \r\n",
                "concept_percentile": "73"
            },
            "9286": {
                "concept_text": "Dermatomyositis is associated with the anti-Jo-1 antibody",
                "concept_percentile": "47"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "4680_B_44",
        "new_question_id": "14712",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "3310",
        "notes_id_link": "1_1892",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Dysfunctional uterine bleeding",
            "Endometriosis",
            "Uterine fibroids",
            "Uterine polyps",
            "Clotting disorders",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "An 18-year-old female patient presents to the GP surgery with a 2-year history of heavy menstrual bleed. She reports that it has been manageable since the start of her menarche at the age of 13 but last 2 years it has become increasingly heavy that it has been causing problems at school. She has to change the sanitary towels every hour on the first 3 days of her periods and has been experiencing significant social embarrassment associated with over-flowing. She reports mild cramping pain on the first 2 days of the menstruation and denies dyspareunia. She is currently not sexually active. You arrange some blood tests which showed a mild iron deficiency anaemia but otherwise normal. An ultrasound revealed a normal looking uterus. <br /><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "Dysfunctional uterine bleeding describes menorrhagia in the absence of underlying pathology.<br /><br />Endometriosis usually presents with pain a few days before the start of the menstruation and deep dyspareunia. <br /><br />Her ultrasound scan is normal hence fibroids and polyps are unlikely.  It is more common in older women.<br /><br />Clotting disorder needs to be ruled out but given the results of the blood test, it is unlikely.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "An 18-year-old female patient presents to the GP surgery with a 2-year history of heavy menstrual bleed. She reports that it has been manageable since the start of her menarche at the age of 13 but last 2 years it has become increasingly heavy that it has been causing problems at school. She has to change the sanitary towels every hour on the first 3 days of her periods and has been experiencing significant social embarrassment associated with over-flowing. She reports mild cramping pain on the first 2 days of the menstruation and denies dyspareunia. She is currently not sexually active. You arrange some blood tests which showed a mild iron deficiency anaemia but otherwise normal. An ultrasound revealed a normal looking uterus. <br /><br />What is the most likely diagnosis?",
        "correct_answer": "1",
        "question_notes": "Dysfunctional uterine bleeding describes menorrhagia in the absence of underlying pathology.<br /><br />Endometriosis usually presents with pain a few days before the start of the menstruation and deep dyspareunia. <br /><br />Her ultrasound scan is normal hence fibroids and polyps are unlikely.  It is more common in older women.<br /><br />Clotting disorder needs to be ruled out but given the results of the blood test, it is unlikely.",
        "answer_order": "1",
        "answer": "1",
        "title": "Menorrhagia: causes",
        "body": "Menorrhagia was previously defined as total blood loss > 80 ml per menses, but it is obviously difficult to quantify. The assessment and management of heavy periods has therefore shifted towards what the woman considers to be excessive and aims to improve quality of life measures. <br /><br />Causes<br /><ul><li>dysfunctional uterine bleeding: this describes menorrhagia in the absence of underlying pathology. This accounts for approximately half of patients</li><li>anovulatory cycles: these are more common at the extremes of a women's reproductive life</li><li>uterine fibroids</li><li>hypothyroidism</li><li>intrauterine devices*</li><li>pelvic inflammatory disease</li><li>bleeding disorders, e.g. von Willebrand disease</li></ul><br />*this refers to normal copper coils. Note that the intrauterine system (Mirena) is used to treat menorrhagia",
        "notes_hash": "0e4d2ad5c1791c0c649b7db3b9a29f33",
        "knowledge_graph_node_id_link": 0,
        "concept": "Dysfunctional uterine bleeding: menorrhagia in the absence of underlying pathology",
        "concept_percentile": "89",
        "concept_colour": "rgb(56,255,0)",
        "number_attempts": "6112",
        "up_votes": "32",
        "down_votes": "50",
        "column_array": [
            0,
            "4646",
            "698",
            "384",
            "46",
            "338",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 10,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    }
]